How much can a telehealth clinic make per patient?

Many cash-pay subscription clinics price ongoing protocols in illustrative bands roughly between $100 and $300 per patient per billing cycle, often monthly, depending on category, medication COGS, and bundle design. Gross revenue per patient is not profit: consult fees, pharmacy fulfillment, processing, and support costs reduce what remains before advertising and fixed overhead. Lifetime value depends on how many months the average patient stays on therapy. A patient at $200 per month who retains twelve months generates roughly $2,400 in gross revenue before costs; one who cancels after month one generates far less. Operators should model retained actives and cohort curves, not single-order hype.

How many patients do you need for $50,000 per month in revenue?

Divide target MRR by average revenue per active patient per month. At $200 per protocol, about 250 retained actives produce roughly $50,000 MRR before expenses. At $100 per protocol, you need about 500 actives. At $300, about 167. These are arithmetic illustrations assuming stable active counts and no refunds; real clinics must subtract churn, pauses, and failed payments. Reaching 250 actives also requires acquisition spend, compliance infrastructure, and fulfillment capacity. The patient count target is simple math; the operating build is what most founders underestimate.

Is telehealth still a good business to start in 2026?

Category demand remains strong in several cash-pay verticals, and virtual care utilization stayed above pre-COVID baselines in many settings. That said, "good business" depends on execution, not headlines. Competition, ad policy, pharmacy supply, and compliance raise the bar versus early low-competition years. Investors who treat telehealth as a regulated operating company with recurring revenue mechanics can still find attractive economics. Those looking for passive or overnight returns usually misread the build complexity. Starting with realistic unit economics, retention planning, and either experienced operators or a structured build partner improves the odds materially.

Getting Started with Telehealth: Opportunity, Market Size, and How Revenue Scales

Telehealth is not a pandemic-era side story anymore. Consumer demand for remote access, monthly medication programs, and digitally native clinics stayed elevated after COVID normalized virtual care. For investors and operators, the opportunity is a recurring-revenue healthcare asset: patients enroll in a protocol, pay on a recurring cadence, and refill on autopilot when retention and fulfillment work. This guide frames the market size, models cash flow at typical per-protocol revenue between roughly $100 and $300 per order cycle, and shows how those unit economics compound as active patient counts scale.

Get Started

Why telehealth is an investable opportunity in 2026

Three structural shifts keep telehealth relevant for capital even after utilization normalized from 2020 peaks:

Behavior stuck: Patients continue using virtual pathways for refills, follow-ups, and lifestyle therapies they started online.
Access gaps: Legacy in-person capacity cannot absorb demand in categories like weight-health, men's health, and HRT.
Subscription-friendly therapies: Many cash-pay protocols bill monthly, which creates MRR-like economics when cohorts retain.

You are not underwriting a fad app. You are underwriting a regulated clinic that sells ongoing therapy programs to consumers who prefer convenience and continuity. The build is heavy, covered in our full telehealth build checklist, but the commercial model is why operators and acquirers keep showing up.

How big is the market?

Headline numbers vary because "telehealth" includes everything from hospital video visits to consumer subscription clinics. Credible framing usually splits two ideas:

Today's reported virtual care revenue is commonly estimated in the tens of billions of dollars for U.S. telehealth services, depending on definition.
Long-run virtualizable spend is larger. McKinsey & Company has framed up to roughly $250 billion of current U.S. healthcare spend as clinically appropriate for virtual delivery where appropriate, an addressable-opportunity lens rather than booked revenue today.

Commercial forecasts from industry researchers often project continued multi-year growth into the 2030s, with consumer cash-pay categories and behavioral health among faster-moving segments. For clinic investors, category tailwinds help the narrative. Unit economics decide whether your clinic captures them. Our 2026 U.S. telehealth market guide walks through definitions, COVID stickiness, and how to read TAM slides without fooling yourself.

Key takeaway: Market size answers "is there room?" Per-protocol economics and retention answer "can this clinic win profitable share?"

What is "revenue per protocol" in a telehealth clinic?

In cash-pay telehealth, a protocol is the packaged therapy a patient is on: consult, medication, follow-up, and refill cadence bundled into a commercial offer. Revenue per protocol usually means what the patient pays per billing cycle, often monthly, not a one-time urgent-care visit.

Operator menus and public clinic pricing commonly cluster in illustrative bands:

~$100 to $150 per cycle: Lighter-touch programs, intro offers, or lower-COGS categories
~$150 to $250 per cycle: Core weight-health, men's health, and HRT subscription price points
~$250 to $300+ per cycle: Premium bundles, multi-medication stacks, or higher-touch consult models

These are educational ranges, not guarantees. Actual pricing depends on medication COGS, consult fees, competitive positioning, and retention strategy. The important pattern: many viable clinics land between $100 and $300 per active patient per order cycle, which is the band we model below.

How cash flow works: from first order to recurring MRR

A simplified patient journey:

Patient converts on a funnel and pays for month one (sometimes an intro price).
Provider reviews intake and prescribes if clinically appropriate.
Pharmacy fulfills; patient stays on protocol if outcomes and experience hold.
Card on file rebills on schedule; revenue repeats without re-acquiring that patient from zero.

That is why telehealth clinics behave like recurring-revenue assets. Month-one spikes look exciting. Months two through six determine whether the business compounds or leaks.

Illustrative monthly recurring revenue by active patients

The table below shows monthly recurring revenue (MRR) at three per-protocol price points and three patient counts. Figures are gross revenue before medication COGS, consult costs, ad spend, software, and processing fees. They are math illustrations, not projections.

$100/protocol/month × 250 active patients = $25,000 MRR (~$300K annualized gross)
$100/protocol/month × 1,000 active patients = $100,000 MRR (~$1.2M annualized gross)
$200/protocol/month × 250 active patients = $50,000 MRR (~$600K annualized gross)
$200/protocol/month × 1,000 active patients = $200,000 MRR (~$2.4M annualized gross)
$300/protocol/month × 250 active patients = $75,000 MRR (~$900K annualized gross)
$300/protocol/month × 1,000 active patients = $300,000 MRR (~$3.6M annualized gross)

At scale, the same math keeps linearity until retention, COGS, or acquisition costs bend the curve. A clinic at $200 per protocol with 2,500 actives is $500,000 MRR before expenses, which is why buyers diligence cohort data, not screenshot revenue.

Get Started

What margins look like after COGS (conceptually)

Gross revenue per protocol is not profit. Typical variable costs include medication and shipping, provider consult fees, payment processing, and portal fees. In many semaglutide-style and men's health models, operators target meaningful gross margin after COGS but before media.

Example sketch at $200/month per patient, purely illustrative:

Medication + fulfillment + consult: $80 to $120 variable
Approximate gross profit per active month: $80 to $120 before ads and fixed ops

If 800 patients retain at that margin band, gross profit before media can reach six figures monthly. Add national acquisition, support staff, and compliance overhead, and the picture gets realistic fast. That is normal. The opportunity is scale with retention, not margin fantasy on slide one.

How revenue scales: three levers

1. More active patients

Media, affiliates, and brand drive new enrollments. Each retained patient adds MRR until they churn. Scaling patient count is the most visible lever and the most capital-intensive because acquisition must stay below lifetime value.

2. Higher revenue per protocol

Bundle labs, add-ons, peptides, or premium consult tiers. Move eligible patients from $149 intro paths to $249 ongoing programs. Pricing power is real but compliance-sensitive. Claims must match clinical scope.

3. Better retention

Improving month-three retention from 45% to 60% can matter more than a twenty percent CAC reduction because LTV extends without re-buying the same customer. Retention is operational: pharmacy speed, support, provider SLAs, and refill UX. See patient retention in subscription telehealth.

Scaling scenarios: from side income to exit candidate

Using $200 per protocol per month as a mid-band example and ignoring churn for simplicity:

~125 actives → ~$25K MRR: Supplemental income territory for many owner-operators
~250 actives → ~$50K MRR: Salary-replacement band before fixed costs
~500 actives → ~$100K MRR: Primary wealth-asset run-rate for a lean clinic
1,000+ actives → $200K+ MRR: Scale and exit-candidate conversation territory with clean books

At $300 per protocol, those thresholds arrive with fewer patients. At $100, you need broader volume or lower CAC. Category choice matters. GLP-1 demand is powerful but competitive, as covered in our GLP-1 telehealth analysis.

Enterprise value: what scale can mean at exit

Strategic buyers and financial acquirers often value telehealth brands on revenue multiples once clinics pass diligence thresholds: LegitScript posture, processor stability, cohort retention, clean ownership, and documented SOPs.

Illustrative exit math, not a forecast: $2.4M annual gross revenue at a 3x multiple implies roughly $7.2M enterprise value before deal structure. Multiples move with growth rate, retention, category risk, and margin. The point for newcomers is that MRR at scale becomes a salable asset, not only monthly cash flow. Design for that from day one, as described in exit-ready clinic diligence.

What can go wrong when scaling

Opportunity slides skip the failure modes. Common ones:

CAC rises while retention flatlines
Processor reserves tighten as chargebacks spike
Pharmacy supply disrupts refill continuity
Ad policy rejects creative that previously worked
Provider coverage gaps block growth in high-CPC states

Our DOs and Don'ts guide lists the sequencing mistakes that turn scaling spend into expensive leaks.

Getting started: the practical path

Seeing the opportunity and modeling MRR is step zero. Launching requires the regulated stack: entity, LegitScript, dual processors, HIPAA portal, multi-state providers, pharmacy contracts, brand, funnels, and compliant creative. Solo builds often take six to twelve months. Structured build-and-transfer programs target roughly ninety active days to a handoff-ready clinic you own outright.

Clinic Builder exists for operators who want the asset and the cash-flow model, not a year of vendor integration. You bring capital and growth ambition. We parallelize the infrastructure, launch with guarantee-tier options on select packages, and transfer credentials against a signed inventory.

Key takeaways

Telehealth opportunity is driven by sticky virtual behavior and subscription-friendly therapy categories, not pandemic emergency use alone.
Market size is large, but clinic success depends on per-protocol economics and retention.
Many cash-pay protocols cluster around $100 to $300 per patient per order cycle.
MRR scales linearly with active patients until COGS, CAC, and churn bend the curve.
At 1,000 actives and $200 per protocol, illustrative MRR is $200,000 per month before expenses.
Exit value becomes relevant when revenue, compliance, and ownership are diligence-ready.

Getting Started with Telehealth: Market Opportunity, Cash Flow, and How Revenue Scales